Patent: 4,481,189
Summary for Patent: 4,481,189
| Title: | Process for preparing sterilized plasma and plasma derivatives |
| Abstract: | A mammalian blood plasma or plasma derivative substantially free of active hepatitis B or non-A, non-B viruses is disclosed, the plasma being characterized by the presence of factor VIII, the percent by weight of denatured factor VIII to the sum of undenatured factor VIII and denatured factor VIII being less than 50%. The plasma is sterilized by contact with a detergent, alcohol or ether, preferably a mixture of detergent and ether, usually followed by removal of the viral sterilizing agent. |
| Inventor(s): | Alfred M. Prince |
| Assignee: | New York Blood Center Inc |
| Application Number: | US06/368,250 |
| Patent Claims: | see list of patent claims |
Details for Patent 4,481,189
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Octapharma Pharmazeutika Produktionsges.m.b.h. | OCTAPLAS | pooled plasma (human), solvent/detergent treated | For Injection | 125416 | January 17, 2013 | ⤷ Start Trial | 2002-04-14 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
